The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) requests public comments to inform the future organization of the Sentine...

expired opportunity(Expired)
From: Federal Government(Federal)
FDARFI10282022

Basic Details

started - 03 Nov, 2022 (17 months ago)

Start Date

03 Nov, 2022 (17 months ago)
due - 12 Dec, 2022 (15 months ago)

Due Date

12 Dec, 2022 (15 months ago)
Bid Notification

Type

Bid Notification
FDARFI10282022

Identifier

FDARFI10282022
HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Customer / Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF (26495)FOOD AND DRUG ADMINISTRATION (2312)FDA CENTER FOR DRUG EVALUATION AND RESEARCH (86)

Attachments (2)

unlockUnlock the best of InstantMarkets.

Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.

Don't have an account yet? Create a free account now.

The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) requests public comments to inform the future organization of the Sentinel System. FDA seeks information that will assist in the exploration of alternative approaches to meet FDA’s legal requirements and fulfill its public health mission by adding value to the Sentinel System.  Specifically, FDA is interested in organizational capabilities that will support the development of an efficient and economical product safety surveillance system that is not limited to the use of a common data model and a distributed data partners network and instead leverages multiple technical approaches.See Attachments for RFI.and Appendix

Silver Spring ,
 MD  20903  USALocation

Place Of Performance : N/A

Country : United StatesState : MarylandCity : Silver Spring

Classification

naicsCode 54171Research and Development in the Physical, Engineering, and Life Sciences
pscCode B537Medical and Health Studies